Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Clin Cancer Res. 2021 Oct 1;27(19):5353–5364. doi: 10.1158/1078-0432.CCR-20-4641

Figure 3. Immunofluorescence staining against granzyme B (in red) of major organs of different treatment groups reveal granzyme B presence in the groups injected with DT + immune checkpoint inhibitors.

Figure 3.

Cell nuclei is stained with DAPI (blue). Magnification 10X.